John Rountree, a consultant for the pharmaceutical industry, is skeptical whether Bayer's acquisition of Monsanto two years ago was a sensible thing to do.
Facebook Messenger Web
The German chemical giant is battling thousands of lawsuits in the US arising from its takeover of rival Monsanto. Despite reaching a settlement in June, Bayer has admitted there are "bumps in the road."
Ever since the German chemicals giant took over Monsanto, it's been fighting a battle to manage the US firm's legacy issues. Bayer's settlement with US plaintiffs is not the end of its troubles, says DW's Henrik Böhme.
Paul Francois had been seeking damages from Monsanto, now a subsidiary of Germany's Bayer, after a 2004 accident with one of its weedkillers. His lawyers argued the firm had failed to give a proper warning of the danger.
US plaintiffs are pursuing the German giant over claims its glyphosate-based weed killers cause cancer. Talks have been ongoing for more than a year.
© 2021 Deutsche Welle |
Legal notice |
| Mobile version